Market Pulse LIVECAST Terminal Movers Brief Politics Macro Calendar

More

Stocks About Why SquawkNews Newsroom Schedule Prediction Markets Disclosure Wire Crypto Search

Market Pulse LIVECAST

Menu

Home Market Pulse LIVECAST Terminal Movers Brief Politics Macro Calendar Stocks About Why SquawkNews Newsroom Schedule Prediction Markets Disclosure Wire Crypto Search

Live News EQUITY L impact Jul 16, 2026, 10:05 AM UTC

UnitedHealth raises FY26 adjusted EPS view to $19.50-$20.00 from over $18.25

Consensus $18.48. Sees...

SquawkNews Newsroom

Consensus $18.48.

Sees...

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

UNH

Related stories

WIT India's Wipro exec: uncertainty continues to shape decision making for clients WIT India's Wipro exec: uncertainty continues to shape decision making for clients L impact | EQUITY | Jul 16, 2026, 11:01 AM UTC CVLT Raise PT to $175 from $125, DDOG to $320 from $225, DT to $53 from $47, NTSK to $16 from $14, RBRK to $100 from $88, SNOW to $325 from CVLT Raise PT to $175 from $125, DDOG to $320 from $225, DT to $53 from $47, NTSK to $16 from $14, RBRK to $100 from $88, SNOW to $325 from $285 and ZS to $185 from $176 following L impact | EQUITY | Jul 16, 2026, 11:00 AM UTC BBWI Bath & Body Works - announces entry into Brazil with first store and digital Destination BBWI Bath & Body Works - announces entry into Brazil with first store and digital Destination L impact | EQUITY | Jul 16, 2026, 11:00 AM UTC GANX gain Therapeutics CEO Gene mack issues letter to shareholders and provides operational update Gain Therapeutics - to commence phase 2 s GANX gain Therapeutics CEO Gene mack issues letter to shareholders and provides operational update Gain Therapeutics - to commence phase 2 study of rexaceract in Q3 2026 L impact | EQUITY | Jul 16, 2026, 11:00 AM UTC INSM Insmed announces positive 12-month data from the ongoing open-label extension study of treprostinil palmitil inhalation powder (tpip) i INSM Insmed announces positive 12-month data from the ongoing open-label extension study of treprostinil palmitil inhalation powder (tpip) in patients with pulmonary arterial hyper L impact | EQUITY | Jul 16, 2026, 11:00 AM UTC POAHY porsche head of production to leave post ahead of schedule, hb reports POAHY porsche head of production to leave post ahead of schedule, hb reports L impact | EQUITY | Jul 16, 2026, 10:59 AM UTC

SQUAWK/NEWS

Real-time financial news agency. Market-moving headlines, macro, politics, filings and audio squawk built for traders.

Pro plan coming — join the list.

Product

LiveCast
Terminal
Brief
Macro
Calendar
Search

For Traders

Market Movers
News for Traders
How to Trade News
What Is a Squawk
Market Pulse
Disclosure Wire

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews robots / sitemap SquawkNews publishes factual market information and context. It is not investment advice and does not provide trade recommendations.

We use analytics (GA4, Clarity, PostHog) to improve the product. Privacy Policy